The company will not receive any proceeds from the sale of its common stock by the selling shareholders in the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SILO:
- Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic
- Silo Pharma announces partnership with CRO for small animal study of SPU-16
- Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide
- Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference
- Silo Pharma to present on SPC-15 at H.C. Wainwright conference